Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSinclair Pharma Regulatory News (SPH)

  • There is currently no data for SPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

16 Jan 2018 14:15

RNS Number : 0385C
Sinclair Pharma PLC
16 January 2018
 

Sinclair Pharma plc

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

London, 16 January 2018 Sinclair Pharma plc (AIM:SPH.L) ("Sinclair" or the "Group"), the international aesthetics company, was advised on 16 January 2018, that today, Julie Spooner, wife of Chris Spooner, Chief Executive Officer, acquired 200,000 ordinary shares of 1p each ("Ordinary Shares") in the Group at an average price of 23.15p per Ordinary Share.

Following these purchases, Chris Spooner's total beneficial interest is 10,440,479 Ordinary Shares, 2.07% of the issued share capital of the Group.

For further information please contact:

Sinclair Pharma plc

Tel: +44 (0) 20 7467 6920

Chris Spooner 

Alan Olby

Andy Crane

 

Peel Hunt LLP (NOMAD and Joint Broker)

Tel: +44 (0) 20 7418 8900

James Steel

Oliver Jackson

 

RBC Capital Markets (Joint Broker)

Tel: +44 (0) 20 7653 4000

Marcus Jackson

Laura White

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Julie Spooner

2.

Reason for the notification

a.

Position/status

Wife of Chris Spooner, Chief Executive Officer

b.

Initial notification

/Amendment

Initial Announcement

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Sinclair Pharma plc

b.

LEI

213800BNMD7JVMHW1772

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type

of instrument

Identification code

Ordinary Shares of 1 pence each in Sinclair Pharma plc

 

 

 

GB0033856740

b.

Nature of the transaction

Purchase

 

c.

Price(s) and volume(s)

 Price(s)

 

Volume(s)

23.15p

200,000

d.

Aggregated information

· Aggregated volume

· Price

 

 

N/A

 

e.

Date of the transaction

2018-01-16

f.

Place of the transaction

London Stock Exchange, AIM

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHZQLFFVFFFBBX
Date   Source Headline
3rd Sep 201812:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
31st Aug 201812:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
30th Aug 20182:58 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc - Restated
30th Aug 201812:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
29th Aug 20185:03 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc - Restated
29th Aug 201812:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
29th Aug 201810:13 amRNSResponse to agreement with Huadong Medicine
28th Aug 20184:41 pmRNSPossible Recommended Cash Offer
28th Aug 201812:00 pmRNSForm 8.5 (EPT/RI)
24th Aug 201812:07 pmRNSForm 8.5 (EPT/RI)
23rd Aug 20182:43 pmRNSExtension of PUSU deadline
23rd Aug 201812:02 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
22nd Aug 201812:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
21st Aug 201812:00 pmRNSForm 8.5 (EPT/RI) Sinclair Pharma Plc
20th Aug 201812:00 pmRNSForm 8.5 (EPT/RI) Sinclair Pharma Plc
17th Aug 201812:00 pmRNSForm 8.5 (EPT/RI) Sinclair Pharma Plc
16th Aug 201812:00 pmRNSForm 8.5 (EPT/RI) Sinclair Pharma Plc
16th Aug 20187:00 amRNSSinclair Pharma PLC - Extension of PUSU deadline
15th Aug 201812:00 pmRNSForm 8.5 (EPT/RI) Sinclair Pharma Plc
14th Aug 201812:00 pmRNSForm 8.5 (EPT/RI) Sinclair Pharma Plc
13th Aug 201812:00 pmRNSForm 8.5 (EPT/RI) Sinclair Pharma Plc
13th Aug 20188:36 amRNSForm 8.5 (EPT/RI) Sinclair Pharma
10th Aug 201812:00 pmRNSForm 8.5 (EPT/RI)
9th Aug 201812:00 pmRNSForm 8.5 (EPT/RI) Sinclair Pharma Plc
8th Aug 201812:00 pmRNSForm 8.5 (EPT/RI) Sinclair Pharma Plc
7th Aug 201812:00 pmRNSForm 8.5 (EPT/RI) Sinclair Pharma Plc
6th Aug 201812:00 pmRNSForm 8.5 (EPT/RI) Sinclair Pharma Plc
3rd Aug 201812:00 pmRNSForm 8.5 (EPT/RI) Sinclair Pharma Plc
2nd Aug 20181:13 pmRNSReplacement Form 8 (OPD) Sinclair Pharma Plc
2nd Aug 201812:00 pmRNSForm 8.5 (EPT/RI) Sinclair Pharma Plc
2nd Aug 20187:00 amRNSExtension of PUSU deadline
1st Aug 201812:14 pmRNSForm 8.5 (EPT/RI) Sinclair Pharma
1st Aug 201812:00 pmRNSForm 8.5 (EPT/RI) Sinclair Pharma Plc
31st Jul 201812:00 pmRNSForm 8.5 (EPT/RI) Sinclair Pharma Plc
30th Jul 201812:00 pmRNSForm 8.5 (EPT/RI) Sinclair Pharma Plc
27th Jul 201812:00 pmRNSForm 8.5 (EPT/RI) Sinclair Pharma Plc
26th Jul 201812:00 pmRNSForm 8.5 (EPT/RI) Sinclair Pharma Plc
26th Jul 201810:38 amRNSForm 8.3 - Sinclair Pharma Plc
25th Jul 201812:00 pmRNSForm 8.5 (EPT/RI) Sinclair Pharma Plc
24th Jul 201812:00 pmRNSForm 8.5 (EPT/RI) Sinclair Pharma Plc
23rd Jul 201812:00 pmRNSForm 8.5 (EPT/RI) Sinclair Pharma Plc
20th Jul 201812:00 pmRNSForm 8.5 (EPT/RI) Sinclair Pharma Plc
19th Jul 201812:14 pmRNSForm 8 (OPD) SINCLAIR PHARMA PLC
19th Jul 201812:00 pmRNSForm 8.5 (EPT/RI) Sinclair Pharma Plc
18th Jul 201812:27 pmRNSForm 8.3 - Sinclair Pharma Plc
18th Jul 201812:00 pmRNSForm 8.5 (EPT/RI) Sinclair Pharma Plc
17th Jul 201812:00 pmRNSForm 8.5 (EPT/RI) Sinclair Pharma Plc
17th Jul 201810:14 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma
16th Jul 201812:00 pmRNSForm 8.5 (EPT/RI) Sinclair Pharma Plc
13th Jul 201812:00 pmRNSForm 8.5 (EPT/RI) Sinclair Pharma Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.